Diversity of the lysozyme fold: structure of the catalytic domain from an unusual endolysin encoded by phage Enc34
Endolysins are bacteriophage-encoded peptidoglycan-degrading enzymes with potential applications for treatment of multidrug-resistant bacterial infections. Hafnia phage Enc34 encodes an unusual endolysin with an N-terminal enzymatically active domain and a C-terminal transmembrane domain. The cataly...
Saved in:
| Published in: | Scientific reports Vol. 12; no. 1; pp. 5005 - 11 |
|---|---|
| Main Authors: | , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
London
Nature Publishing Group UK
23.03.2022
Nature Publishing Group Nature Portfolio |
| Subjects: | |
| ISSN: | 2045-2322, 2045-2322 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Endolysins are bacteriophage-encoded peptidoglycan-degrading enzymes with potential applications for treatment of multidrug-resistant bacterial infections.
Hafnia
phage Enc34 encodes an unusual endolysin with an N-terminal enzymatically active domain and a C-terminal transmembrane domain. The catalytic domain of the endolysin belongs to the conserved protein family PHA02564 which has no recognizable sequence similarity to other known endolysin types. Turbidity reduction assays indicate that the Enc34 enzyme is active against peptidoglycan from a variety of Gram-negative bacteria including the opportunistic pathogen
Pseudomonas aeruginosa
PAO1. The crystal structure of the catalytic domain of the Enc34 endolysin shows a distinctive all-helical architecture that distantly resembles the α-lobe of the lysozyme fold. Conserved catalytically important residues suggest a shared evolutionary history between the Enc34 endolysin and GH73 and GH23 family glycoside hydrolases and propose a molecular signature for substrate cleavage for a large group of peptidoglycan-degrading enzymes. |
|---|---|
| AbstractList | Endolysins are bacteriophage-encoded peptidoglycan-degrading enzymes with potential applications for treatment of multidrug-resistant bacterial infections.
Hafnia
phage Enc34 encodes an unusual endolysin with an N-terminal enzymatically active domain and a C-terminal transmembrane domain. The catalytic domain of the endolysin belongs to the conserved protein family PHA02564 which has no recognizable sequence similarity to other known endolysin types. Turbidity reduction assays indicate that the Enc34 enzyme is active against peptidoglycan from a variety of Gram-negative bacteria including the opportunistic pathogen
Pseudomonas aeruginosa
PAO1. The crystal structure of the catalytic domain of the Enc34 endolysin shows a distinctive all-helical architecture that distantly resembles the α-lobe of the lysozyme fold. Conserved catalytically important residues suggest a shared evolutionary history between the Enc34 endolysin and GH73 and GH23 family glycoside hydrolases and propose a molecular signature for substrate cleavage for a large group of peptidoglycan-degrading enzymes. Endolysins are bacteriophage-encoded peptidoglycan-degrading enzymes with potential applications for treatment of multidrug-resistant bacterial infections. Hafnia phage Enc34 encodes an unusual endolysin with an N-terminal enzymatically active domain and a C-terminal transmembrane domain. The catalytic domain of the endolysin belongs to the conserved protein family PHA02564 which has no recognizable sequence similarity to other known endolysin types. Turbidity reduction assays indicate that the Enc34 enzyme is active against peptidoglycan from a variety of Gram-negative bacteria including the opportunistic pathogen Pseudomonas aeruginosa PAO1. The crystal structure of the catalytic domain of the Enc34 endolysin shows a distinctive all-helical architecture that distantly resembles the α-lobe of the lysozyme fold. Conserved catalytically important residues suggest a shared evolutionary history between the Enc34 endolysin and GH73 and GH23 family glycoside hydrolases and propose a molecular signature for substrate cleavage for a large group of peptidoglycan-degrading enzymes. Abstract Endolysins are bacteriophage-encoded peptidoglycan-degrading enzymes with potential applications for treatment of multidrug-resistant bacterial infections. Hafnia phage Enc34 encodes an unusual endolysin with an N-terminal enzymatically active domain and a C-terminal transmembrane domain. The catalytic domain of the endolysin belongs to the conserved protein family PHA02564 which has no recognizable sequence similarity to other known endolysin types. Turbidity reduction assays indicate that the Enc34 enzyme is active against peptidoglycan from a variety of Gram-negative bacteria including the opportunistic pathogen Pseudomonas aeruginosa PAO1. The crystal structure of the catalytic domain of the Enc34 endolysin shows a distinctive all-helical architecture that distantly resembles the α-lobe of the lysozyme fold. Conserved catalytically important residues suggest a shared evolutionary history between the Enc34 endolysin and GH73 and GH23 family glycoside hydrolases and propose a molecular signature for substrate cleavage for a large group of peptidoglycan-degrading enzymes. Endolysins are bacteriophage-encoded peptidoglycan-degrading enzymes with potential applications for treatment of multidrug-resistant bacterial infections. Hafnia phage Enc34 encodes an unusual endolysin with an N-terminal enzymatically active domain and a C-terminal transmembrane domain. The catalytic domain of the endolysin belongs to the conserved protein family PHA02564 which has no recognizable sequence similarity to other known endolysin types. Turbidity reduction assays indicate that the Enc34 enzyme is active against peptidoglycan from a variety of Gram-negative bacteria including the opportunistic pathogen Pseudomonas aeruginosa PAO1. The crystal structure of the catalytic domain of the Enc34 endolysin shows a distinctive all-helical architecture that distantly resembles the α-lobe of the lysozyme fold. Conserved catalytically important residues suggest a shared evolutionary history between the Enc34 endolysin and GH73 and GH23 family glycoside hydrolases and propose a molecular signature for substrate cleavage for a large group of peptidoglycan-degrading enzymes.Endolysins are bacteriophage-encoded peptidoglycan-degrading enzymes with potential applications for treatment of multidrug-resistant bacterial infections. Hafnia phage Enc34 encodes an unusual endolysin with an N-terminal enzymatically active domain and a C-terminal transmembrane domain. The catalytic domain of the endolysin belongs to the conserved protein family PHA02564 which has no recognizable sequence similarity to other known endolysin types. Turbidity reduction assays indicate that the Enc34 enzyme is active against peptidoglycan from a variety of Gram-negative bacteria including the opportunistic pathogen Pseudomonas aeruginosa PAO1. The crystal structure of the catalytic domain of the Enc34 endolysin shows a distinctive all-helical architecture that distantly resembles the α-lobe of the lysozyme fold. Conserved catalytically important residues suggest a shared evolutionary history between the Enc34 endolysin and GH73 and GH23 family glycoside hydrolases and propose a molecular signature for substrate cleavage for a large group of peptidoglycan-degrading enzymes. |
| ArticleNumber | 5005 |
| Author | Cernooka, Elina Tars, Kaspars Zrelovs, Nikita Kazaks, Andris Rumnieks, Janis |
| Author_xml | – sequence: 1 givenname: Elina surname: Cernooka fullname: Cernooka, Elina organization: Latvian Biomedical Research and Study Centre – sequence: 2 givenname: Janis surname: Rumnieks fullname: Rumnieks, Janis organization: Latvian Biomedical Research and Study Centre – sequence: 3 givenname: Nikita surname: Zrelovs fullname: Zrelovs, Nikita organization: Latvian Biomedical Research and Study Centre – sequence: 4 givenname: Kaspars surname: Tars fullname: Tars, Kaspars organization: Latvian Biomedical Research and Study Centre, Faculty of Biology, University of Latvia – sequence: 5 givenname: Andris surname: Kazaks fullname: Kazaks, Andris email: andris@biomed.lu.lv organization: Latvian Biomedical Research and Study Centre |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35322067$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Uk1v1DAQjVARLaV_gAOyxIVLij_ixOGAVJVSKlXiAmdrYk92s0rsxXYqhV-Pu9uWtof6YmvmvTdvxvO2OHDeYVG8Z_SUUaE-x4rJVpWU85KqppYle1UccVrJkgvODx69D4uTGDc0H8nbirVvikMhc5zWzVERvg03GOKQFuJ7ktZIxiX6v8uEpPej_UJiCrNJc8D7vIEE45IGQ6yfYHCkD34i4Mjs5jjDSNBZn0VyBp3xFi3pFrJdwwrJhTOiele87mGMeHJ3Hxe_v1_8Ov9RXv-8vDo_uy5N1dBUtlT2WCtZM2yQQguUGwCOgvZtk9vuKmWbDphgUnYtAnS2rYS0naml6iiK4-Jqr2s9bPQ2DBOERXsY9C7gw0pDyH2MqOvWyp4p7IDLCpEDrS01PBe0LbWtyVpf91rbuZvQGnQpwPhE9GnGDWu98jdaZU9Uyizw6U4g-D8zxqSnIRocR3Do56h5XXGlpKpUhn58Bt34Obg8qh2KqVrUIqM-PHb0YOX-azOA7wEm-BgD9g8QRvXtCun9Cuk8S71bIc0yST0jmSFBGvxtV8P4MlXsqTHXcSsM_22_wPoHb4rb5A |
| CitedBy_id | crossref_primary_10_1016_j_biotechadv_2023_108116 crossref_primary_10_1016_j_bbapap_2023_140918 crossref_primary_10_3390_v14091842 crossref_primary_10_3390_ijms251910838 crossref_primary_10_3390_molecules29225386 crossref_primary_10_1038_s44319_024_00060_6 crossref_primary_10_1002_1873_3468_70042 crossref_primary_10_1093_femsle_fnae103 crossref_primary_10_1186_s12866_023_02832_x crossref_primary_10_3390_cryst15050448 crossref_primary_10_1186_s12866_025_03884_x |
| Cites_doi | 10.1093/nar/gkw408 10.1107/S0907444909047337 10.1057/s41599-020-0478-4 10.1038/s41598-018-37417-6 10.1007/s00253-011-3104-y 10.1107/S0907444910007493 10.1073/pnas.0400957101 10.1007/s00253-003-1522-1 10.1093/molbev/msaa015 10.3390/antibiotics9040155 10.1007/978-1-0716-1290-3_23 10.1046/j.1365-2958.1999.01501.x 10.3389/fmicb.2018.01033 10.2217/fmb.15.8 10.4161/bact.1.1.14868 10.1107/S1600576716004416 10.1002/pro.3330 10.3389/fmicb.2021.748718 10.1007/s12275-014-4087-z 10.3390/v11030268 10.1002/pro.3749 10.1093/glycob/cwu113 10.1016/j.biotechadv.2017.12.009 10.1111/mmi.14134 10.1093/molbev/mst024 10.1186/s12859-018-2342-8 10.1128/MRA.00188-19 10.1016/j.ijantimicag.2019.11.001 10.1038/s41587-019-0036-z 10.1038/nmeth.4285 10.1016/j.jbbm.2006.10.009 10.1016/S1473-3099(20)30327-3 10.1107/S0021889807021206 10.1074/jbc.M709398200 10.1107/S0907444911001314 10.1128/JVI.01954-12 10.1038/s41564-019-0531-5 10.3390/molecules22071038 10.1006/jmbi.2000.4315 10.1007/s00018-004-4301-y 10.1038/nature10388 10.32607/20758251-2017-9-1-81-87 10.1093/nar/gki408 10.1107/S2059798319011471 10.3390/microorganisms8030447 10.1021/cb500439c 10.1093/nar/gkn201 10.1111/j.1574-6976.2007.00094.x 10.1038/msb.2011.75 10.2217/fmb.12.97 10.3390/v13040680 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 2022. The Author(s). The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. The Author(s). – notice: The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM DOA |
| DOI | 10.1038/s41598-022-08765-1 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection PML(ProQuest Medical Library) Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2045-2322 |
| EndPage | 11 |
| ExternalDocumentID | oai_doaj_org_article_69d5f18eba254ee2a06d0c22cad90d9c PMC8943055 35322067 10_1038_s41598_022_08765_1 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: European Social Fund grantid: 8.2.2.0/20/I/006 funderid: http://dx.doi.org/10.13039/501100004895 – fundername: SIA “Mikrotīkls” – fundername: ; – fundername: ; grantid: 8.2.2.0/20/I/006 |
| GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFFHD AFPKN CITATION PHGZM PHGZT PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM 7XB 8FK K9. PKEHL PQEST PQUKI Q9U 7X8 5PM |
| ID | FETCH-LOGICAL-c470t-905fe68561e7e0a9a02caa2e30f97022b48d7ba13155b9eaabd9435dbc658b0e3 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 11 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000772605500123&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2045-2322 |
| IngestDate | Tue Oct 14 14:59:15 EDT 2025 Tue Nov 04 01:58:38 EST 2025 Sun Nov 09 14:28:20 EST 2025 Tue Oct 07 07:41:20 EDT 2025 Wed Apr 16 06:21:38 EDT 2025 Tue Nov 18 21:43:58 EST 2025 Sat Nov 29 06:25:41 EST 2025 Fri Feb 21 02:39:01 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | 2022. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c470t-905fe68561e7e0a9a02caa2e30f97022b48d7ba13155b9eaabd9435dbc658b0e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/2642186363?pq-origsite=%requestingapplication% |
| PMID | 35322067 |
| PQID | 2642186363 |
| PQPubID | 2041939 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_69d5f18eba254ee2a06d0c22cad90d9c pubmedcentral_primary_oai_pubmedcentral_nih_gov_8943055 proquest_miscellaneous_2642885848 proquest_journals_2642186363 pubmed_primary_35322067 crossref_primary_10_1038_s41598_022_08765_1 crossref_citationtrail_10_1038_s41598_022_08765_1 springer_journals_10_1038_s41598_022_08765_1 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-03-23 |
| PublicationDateYYYYMMDD | 2022-03-23 |
| PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-23 day: 23 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Scientific reports |
| PublicationTitleAbbrev | Sci Rep |
| PublicationTitleAlternate | Sci Rep |
| PublicationYear | 2022 |
| Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
| Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
| References | SieversFFast, scalable generation of high-quality protein multiple sequence alignments using Clustal OmegaMol. Syst. Biol.2011753921988835326169910.1038/msb.2011.75 BriersYLavigneRVolckaertGHertveldtKA standardized approach for accurate quantification of murein hydrolase activity in high-throughput assaysJ. Biochem. Biophys. Methods2007705315331:CAS:528:DC%2BD2sXislKjtLo%3D1716943510.1016/j.jbbm.2006.10.009 VasinaDVDiscovering the potentials of four phage endolysins to combat Gram-negative infectionsFront. Microbiol.20211234721353854876910.3389/fmicb.2021.748718 OritoYMoritaMHoriKUnnoHTanjiYBacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysisAppl. Microbiol. Biotechnol.2004651051091:CAS:528:DC%2BD2cXkvF2mt7c%3D1471415110.1007/s00253-003-1522-1 Interagency Coordination Group on Antimicrobial Resistance. No time to wait: Securing the future from drug-resistant infections report to the Secretary-General of the United Nations. https://www.who.int/antimicrobial-resistance/interagency-coordination-group/IACG_final_report_EN.pdf?ua=1 (Accessed 30 Oct 2021) (2019). MurshudovGNREFMAC5 for the refinement of macromolecular crystal structuresActa Crystallogr. D Biol. Crystallogr.2011673553671:CAS:528:DC%2BC3MXktFWqtbk%3D21460454306975110.1107/S0907444911001314 Fernández-RuizICoutinhoFHRodriguez-ValeraFThousands of novel endolysins discovered in uncultured phage genomesFront. Microbiol.20189103329867909596886410.3389/fmicb.2018.01033 SpiwokVCH/π interactions in carbohydrate recognitionMolecules2017221038615232010.3390/molecules22071038 WaglechnerNMcArthurAGWrightGDPhylogenetic reconciliation reveals the natural history of glycopeptide antibiotic biosynthesis and resistanceNat. Microbiol.20194186218711:CAS:528:DC%2BC1MXhsFKhtbbL3140633410.1038/s41564-019-0531-5 Rambaut, A. FigTree v. 1.4.4. http://tree.bio.ed.ac.uk/software/figtree/ (2018). ChertkovOVDual active site in the endolytic transglycosylase gp144 of bacteriophage phiKZActa Nat.2017981871:STN:280:DC%2BC1crjtVKjug%3D%3D10.32607/20758251-2017-9-1-81-87 BriersYPeetersLMVolckaertGLavigneRThe lysis cassette of bacteriophage ϕKMV encodes a signal-arrest-release endolysin and a pinholinBacteriophage20111253021687532310945110.4161/bact.1.1.14868 SchmelcherMDonovanDMLoessnerMJBacteriophage endolysins as novel antimicrobialsFuture Microbiol.20127114711711:CAS:528:DC%2BC38XhsVCjtb7F2303042210.2217/fmb.12.97 SpartaKMKrugMHeinemannUMuellerUWeissMSXDSAPP2.0J. Appl. Crystallogr.2016491085109210.1107/S1600576716004416 WilliamsCJMolProbity: More and better reference data for improved all-atom structure validationProtein Sci.2018272933151:CAS:528:DC%2BC2sXhvVKgsrnO2906776610.1002/pro.3330 KabschWXDSActa Crystallogr. D Biol. Crystallogr.2010661251321:CAS:528:DC%2BC3cXhs1SisLc%3D20124692281566510.1107/S0907444909047337 LiebschnerDMacromolecular structure determination using X-rays, neutrons and electrons: Recent developments in PhenixActa Crystallogr. D Struct. Biol.2019758618771:CAS:528:DC%2BC1MXhvFWkurrO31588918677885210.1107/S2059798319011471 GraschopfABläsiUMolecular function of the dual-start motif in the lambda S holinMol. Microbiol.1999335695821:CAS:528:DyaK1MXlslSjur4%3D1041764710.1046/j.1365-2958.1999.01501.x FokineAMiroshnikovKAShneiderMMMesyanzhinovVVRossmannMGStructure of the bacteriophage phiKZ lytic transglycosylase gp144J. Biol. Chem.2008283724275501:CAS:528:DC%2BD1cXivFyisr8%3D1816039410.1074/jbc.M709398200 EmsleyPLohkampBScottWGCowtanKFeatures and development of CootActa Crystallogr. D Biol. Crystallogr.2010664865011:CAS:528:DC%2BC3cXksFKisb8%3D20383002285231310.1107/S0907444910007493 YoungRPhage lysis: Three steps, three choices, one outcomeJ. Microbiol.2014522432581:CAS:528:DC%2BC2cXjs1Gisbc%3D24585055401243110.1007/s12275-014-4087-z MinhBQIQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic eraMol. Biol. Evol.202037153015341:CAS:528:DC%2BB3cXis1egsLbL32011700718220610.1093/molbev/msaa015 LavigneRBriersYHertveldtKRobbenJVolckaertGIdentification and characterization of a highly thermostable bacteriophage lysozymeCell. Mol. Life Sci.200461275327591:CAS:528:DC%2BD2cXhtFGit7vN1554917810.1007/s00018-004-4301-y MurrayEDraperLARossRPHillCThe advantages and challenges of using endolysins in a clinical settingViruses2021136801:CAS:528:DC%2BB3MXhtVSjsrrE33920965807125910.3390/v13040680 LaiMJAntibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteriaAppl. Microbiol. Biotechnol.2011905295391:CAS:528:DC%2BC3MXjsFGhs7Y%3D2126446610.1007/s00253-011-3104-y KimBOPhage-derived antibacterials: Harnessing the simplicity, plasticity, and diversity of phagesViruses2019112681:CAS:528:DC%2BC1MXhslymur3J646613010.3390/v11030268 LipskiAStructural and biochemical characterization of the β-N-acetylglucosaminidase from Thermotoga maritima: Toward rationalization of mechanistic knowledge in the GH73 familyGlycobiology2015253193301:CAS:528:DC%2BC28Xht1Wqu77O2534444510.1093/glycob/cwu113 SödingJBiegertALupasANThe HHpred interactive server for protein homology detection and structure predictionNucleic Acids Res.200533W244W24815980461116016910.1093/nar/gki408 MinhBQNguyenMAvon HaeselerAUltrafast approximation for phylogenetic bootstrapMol. Biol. Evol.201330118811951:CAS:528:DC%2BC3sXlvFWgsb0%3D23418397367074110.1093/molbev/mst024 VentolaCLThe antibiotic resistance crisis: Part 2: Management strategies and new agentsP T201540344352259878234422635 JohnsonMNCBI BLAST: A better web interfaceNucleic Acids Res.200836W5W91:CAS:528:DC%2BD1cXptlKrs70%3D18440982244771610.1093/nar/gkn201 McCoyAJPhaser crystallographic softwareJ. Appl. Crystallogr.2007406586741:CAS:528:DC%2BD2sXnslWqsLk%3D19461840248347210.1107/S0021889807021206 D’CostaVMAntibiotic resistance is ancientNature2011477457461218815612011Natur.477..457D10.1038/nature10388 KazaksADislersALipowskyGNikolajevaVTarsKComplete genome sequence of the Enterobacter cancerogenus bacteriophage Enc34J. Virol.20128611403114041:CAS:528:DC%2BC38XhsVyqsr3I22997422345718510.1128/JVI.01954-12 BriersYLavigneRBreaking barriers: Expansion of the use of endolysins as novel antibacterials against Gram-negative bacteriaFuture Microbiol.2015103773901:CAS:528:DC%2BC2MXltlCrsLw%3D2581246110.2217/fmb.15.8 MaganaMThe value of antimicrobial peptides in the age of resistanceLancet Infect. Dis.202020e216e2301:CAS:528:DC%2BB3cXhtl2rsLrK3265307010.1016/S1473-3099(20)30327-3 BaiJLeeSRyuSIdentification and in vitro characterization of a novel phage endolysin that targets Gram-negative bacteriaMicroorganisms202084471:CAS:528:DC%2BB3cXhsVWjsLfE714399210.3390/microorganisms8030447 KroghALarssonBvon HeijneGSonnhammerELPredicting transmembrane protein topology with a hidden Markov model: Application to complete genomesJ. Mol. Biol.20013055675801:CAS:528:DC%2BD3MXisFCguw%3D%3D1115261310.1006/jmbi.2000.4315 VollmerWBlanotDde PedroMAPeptidoglycan structure and architectureFEMS Microbiol. Rev.2008321491671:CAS:528:DC%2BD1cXjt1Git7k%3D1819433610.1111/j.1574-6976.2007.00094.x BrivesCPourrazJPhage therapy as a potential solution in the fight against AMR: Obstacles and possible futuresPalgrave Commun.2020610010.1057/s41599-020-0478-4 O’LearyCXieYKongariRGillJJLiuMComplete genome sequence of Salmonella enterica serovar Typhimurium siphophage SiskinMicrobiol. Resour. Announc.20198e00188e21931048394649822710.1128/MRA.00188-19 PlotkaMStructure and function of the Ts2631 endolysin of Thermus scotoductus phage vB_Tsc2631 with unique N-terminal extension used for peptidoglycan bindingSci. Rep.2019912613071861163619862019NatSR...9.1261P10.1038/s41598-018-37417-6 KalyaanamoorthySMinhBQWongTvon HaeselerAJermiinLSModelFinder: Fast model selection for accurate phylogenetic estimatesNat. Methods2017145875891:CAS:528:DC%2BC2sXntFKitbw%3D28481363545324510.1038/nmeth.4285 Schrödinger, L. & DeLano, W. PyMOL. http://www.pymol.org/pymol (2020). ZurawskiDVMcLendonMKMonoclonal antibodies as an antibacterial approach against bacterial pathogensAntibiotics (Basel)202091551:CAS:528:DC%2BB3cXitF2ht77N10.3390/antibiotics9040155 BroendumSSBuckleAMMcGowanSCatalytic diversity and cell wall binding repeats in the phage-encoded endolysinsMol. Microbiol.20181108798961:CAS:528:DC%2BC1cXitFOis7jK3023064210.1111/mmi.14134 HolmLDALI and the persistence of protein shapeProtein Sci.2020291281401:CAS:528:DC%2BC1MXitFWjsbzO3160689410.1002/pro.3749 KongariRPhage spanins: Diversity, topological dynamics and gene convergenceBMC Bioinform.2018193261:CAS:528:DC%2BC1MXht1Sks7%2FO10.1186/s12859-018-2342-8 GerstmansHCrielBBriersYSynthetic biology of modular endolysinsBiotechnol. Adv.2018366246401:CAS:528:DC%2BC1cXkvFyhtg%3D%3D2924868210.1016/j.biotechadv.2017.12.009 XuMStruckDKDeatonJWangINYoungRA signal-arrest-release sequence mediates export and control of the phage P1 endolysinProc. Natl. Acad. Sci. U.S.A.2004101641564201:CAS:528:DC%2BD2cXjvVyit7k%3D150906504040592004PNAS..101.6415X10.1073/pnas.0400957101 CernookaERumnieksJKazaksAStructural characterization of a single-stranded DNA-binding protein: A case study of the ORF6 protein from bacteriophage Enc34Methods Mol. Biol.202122813433731:CAS:528:DC%2BB3MXisFals7%2FK3384797110.1007/978-1-0716-1290-3_23 GondilVSHarjaiKChhibberSEndolysins as emerging alternative therapeutic agents to counter drug-resistant infectionsInt. J. Antimicrob. Agents2020551:CAS:528:DC%2BB3cXht1Sit7c%3D3171525710.1016/j.ijantimicag.2019.11.001 AshkenazyHConSurf 2016: An improved methodology to estimate and visualize evolutionary conservation in macromoleculesNucleic Acids Res.201644W344W3501:CAS:528:DC%2BC2sXhtV2itrrJ27166375498794010.1093/nar/gkw408 Artola-RecolonsCStructure and cell wall cleavage by modular lytic transglycosylase MltC of Escherichia coliACS Chem. Biol.20149205820661:CAS:528:DC%2BC2cXhtVyitLzK24988330416878310.1021/cb500439c Almagro ArmenterosJJSignalP 5.0 improves signal peptide predictions using deep neural networksNat. Biotechnol.2019374204231:CAS:528:DC%2BC1MXosV2qs78%3 D Liebschner (8765_CR51) 2019; 75 CL Ventola (8765_CR4) 2015; 40 W Vollmer (8765_CR23) 2008; 32 L Holm (8765_CR25) 2020; 29 V Spiwok (8765_CR37) 2017; 22 Y Briers (8765_CR15) 2015; 10 M Plotka (8765_CR32) 2019; 9 GN Murshudov (8765_CR53) 2011; 67 OV Chertkov (8765_CR28) 2017; 9 H Gerstmans (8765_CR13) 2018; 36 BQ Minh (8765_CR43) 2020; 37 8765_CR1 SS Broendum (8765_CR14) 2018; 110 J Söding (8765_CR39) 2005; 33 A Kazaks (8765_CR19) 2012; 86 R Kongari (8765_CR21) 2018; 19 C Artola-Recolons (8765_CR36) 2014; 9 I Fernández-Ruiz (8765_CR18) 2018; 9 A Graschopf (8765_CR20) 1999; 33 BO Kim (8765_CR7) 2019; 11 8765_CR24 C O’Leary (8765_CR29) 2019; 8 VS Gondil (8765_CR12) 2020; 55 M Magana (8765_CR5) 2020; 20 Y Orito (8765_CR31) 2004; 65 N Waglechner (8765_CR2) 2019; 4 E Cernooka (8765_CR47) 2021; 2281 CJ Williams (8765_CR55) 2018; 27 C Brives (8765_CR8) 2020; 6 R Young (8765_CR33) 2014; 52 A Lipski (8765_CR27) 2015; 25 P Emsley (8765_CR52) 2010; 66 E Murray (8765_CR9) 2021; 13 Y Briers (8765_CR22) 2007; 70 DV Zurawski (8765_CR6) 2020; 9 VM D’Costa (8765_CR3) 2011; 477 M Johnson (8765_CR38) 2008; 36 JJ Almagro Armenteros (8765_CR41) 2019; 37 DV Vasina (8765_CR11) 2021; 12 M Schmelcher (8765_CR10) 2012; 7 J Bai (8765_CR30) 2020; 8 KM Sparta (8765_CR50) 2016; 49 Y Briers (8765_CR34) 2011; 1 A Fokine (8765_CR35) 2008; 283 S Kalyaanamoorthy (8765_CR44) 2017; 14 8765_CR46 R Lavigne (8765_CR48) 2004; 61 W Kabsch (8765_CR49) 2010; 66 MJ Lai (8765_CR17) 2011; 90 H Ashkenazy (8765_CR26) 2016; 44 BQ Minh (8765_CR45) 2013; 30 AJ McCoy (8765_CR54) 2007; 40 A Krogh (8765_CR40) 2001; 305 F Sievers (8765_CR42) 2011; 7 M Xu (8765_CR16) 2004; 101 |
| References_xml | – reference: MaganaMThe value of antimicrobial peptides in the age of resistanceLancet Infect. Dis.202020e216e2301:CAS:528:DC%2BB3cXhtl2rsLrK3265307010.1016/S1473-3099(20)30327-3 – reference: LavigneRBriersYHertveldtKRobbenJVolckaertGIdentification and characterization of a highly thermostable bacteriophage lysozymeCell. Mol. Life Sci.200461275327591:CAS:528:DC%2BD2cXhtFGit7vN1554917810.1007/s00018-004-4301-y – reference: McCoyAJPhaser crystallographic softwareJ. Appl. Crystallogr.2007406586741:CAS:528:DC%2BD2sXnslWqsLk%3D19461840248347210.1107/S0021889807021206 – reference: MurrayEDraperLARossRPHillCThe advantages and challenges of using endolysins in a clinical settingViruses2021136801:CAS:528:DC%2BB3MXhtVSjsrrE33920965807125910.3390/v13040680 – reference: KroghALarssonBvon HeijneGSonnhammerELPredicting transmembrane protein topology with a hidden Markov model: Application to complete genomesJ. Mol. Biol.20013055675801:CAS:528:DC%2BD3MXisFCguw%3D%3D1115261310.1006/jmbi.2000.4315 – reference: EmsleyPLohkampBScottWGCowtanKFeatures and development of CootActa Crystallogr. D Biol. Crystallogr.2010664865011:CAS:528:DC%2BC3cXksFKisb8%3D20383002285231310.1107/S0907444910007493 – reference: WaglechnerNMcArthurAGWrightGDPhylogenetic reconciliation reveals the natural history of glycopeptide antibiotic biosynthesis and resistanceNat. Microbiol.20194186218711:CAS:528:DC%2BC1MXhsFKhtbbL3140633410.1038/s41564-019-0531-5 – reference: XuMStruckDKDeatonJWangINYoungRA signal-arrest-release sequence mediates export and control of the phage P1 endolysinProc. Natl. Acad. Sci. U.S.A.2004101641564201:CAS:528:DC%2BD2cXjvVyit7k%3D150906504040592004PNAS..101.6415X10.1073/pnas.0400957101 – reference: VentolaCLThe antibiotic resistance crisis: Part 2: Management strategies and new agentsP T201540344352259878234422635 – reference: ZurawskiDVMcLendonMKMonoclonal antibodies as an antibacterial approach against bacterial pathogensAntibiotics (Basel)202091551:CAS:528:DC%2BB3cXitF2ht77N10.3390/antibiotics9040155 – reference: D’CostaVMAntibiotic resistance is ancientNature2011477457461218815612011Natur.477..457D10.1038/nature10388 – reference: MurshudovGNREFMAC5 for the refinement of macromolecular crystal structuresActa Crystallogr. D Biol. Crystallogr.2011673553671:CAS:528:DC%2BC3MXktFWqtbk%3D21460454306975110.1107/S0907444911001314 – reference: Almagro ArmenterosJJSignalP 5.0 improves signal peptide predictions using deep neural networksNat. Biotechnol.2019374204231:CAS:528:DC%2BC1MXosV2qs78%3D3077823310.1038/s41587-019-0036-z – reference: YoungRPhage lysis: Three steps, three choices, one outcomeJ. Microbiol.2014522432581:CAS:528:DC%2BC2cXjs1Gisbc%3D24585055401243110.1007/s12275-014-4087-z – reference: BroendumSSBuckleAMMcGowanSCatalytic diversity and cell wall binding repeats in the phage-encoded endolysinsMol. Microbiol.20181108798961:CAS:528:DC%2BC1cXitFOis7jK3023064210.1111/mmi.14134 – reference: SpiwokVCH/π interactions in carbohydrate recognitionMolecules2017221038615232010.3390/molecules22071038 – reference: O’LearyCXieYKongariRGillJJLiuMComplete genome sequence of Salmonella enterica serovar Typhimurium siphophage SiskinMicrobiol. Resour. Announc.20198e00188e21931048394649822710.1128/MRA.00188-19 – reference: OritoYMoritaMHoriKUnnoHTanjiYBacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysisAppl. Microbiol. Biotechnol.2004651051091:CAS:528:DC%2BD2cXkvF2mt7c%3D1471415110.1007/s00253-003-1522-1 – reference: SpartaKMKrugMHeinemannUMuellerUWeissMSXDSAPP2.0J. Appl. Crystallogr.2016491085109210.1107/S1600576716004416 – reference: SchmelcherMDonovanDMLoessnerMJBacteriophage endolysins as novel antimicrobialsFuture Microbiol.20127114711711:CAS:528:DC%2BC38XhsVCjtb7F2303042210.2217/fmb.12.97 – reference: BriersYLavigneRVolckaertGHertveldtKA standardized approach for accurate quantification of murein hydrolase activity in high-throughput assaysJ. Biochem. Biophys. Methods2007705315331:CAS:528:DC%2BD2sXislKjtLo%3D1716943510.1016/j.jbbm.2006.10.009 – reference: KabschWXDSActa Crystallogr. D Biol. Crystallogr.2010661251321:CAS:528:DC%2BC3cXhs1SisLc%3D20124692281566510.1107/S0907444909047337 – reference: Fernández-RuizICoutinhoFHRodriguez-ValeraFThousands of novel endolysins discovered in uncultured phage genomesFront. Microbiol.20189103329867909596886410.3389/fmicb.2018.01033 – reference: PlotkaMStructure and function of the Ts2631 endolysin of Thermus scotoductus phage vB_Tsc2631 with unique N-terminal extension used for peptidoglycan bindingSci. Rep.2019912613071861163619862019NatSR...9.1261P10.1038/s41598-018-37417-6 – reference: BrivesCPourrazJPhage therapy as a potential solution in the fight against AMR: Obstacles and possible futuresPalgrave Commun.2020610010.1057/s41599-020-0478-4 – reference: JohnsonMNCBI BLAST: A better web interfaceNucleic Acids Res.200836W5W91:CAS:528:DC%2BD1cXptlKrs70%3D18440982244771610.1093/nar/gkn201 – reference: VasinaDVDiscovering the potentials of four phage endolysins to combat Gram-negative infectionsFront. Microbiol.20211234721353854876910.3389/fmicb.2021.748718 – reference: SieversFFast, scalable generation of high-quality protein multiple sequence alignments using Clustal OmegaMol. Syst. Biol.2011753921988835326169910.1038/msb.2011.75 – reference: WilliamsCJMolProbity: More and better reference data for improved all-atom structure validationProtein Sci.2018272933151:CAS:528:DC%2BC2sXhvVKgsrnO2906776610.1002/pro.3330 – reference: Schrödinger, L. & DeLano, W. PyMOL. http://www.pymol.org/pymol (2020). – reference: MinhBQIQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic eraMol. Biol. Evol.202037153015341:CAS:528:DC%2BB3cXis1egsLbL32011700718220610.1093/molbev/msaa015 – reference: Interagency Coordination Group on Antimicrobial Resistance. No time to wait: Securing the future from drug-resistant infections report to the Secretary-General of the United Nations. https://www.who.int/antimicrobial-resistance/interagency-coordination-group/IACG_final_report_EN.pdf?ua=1 (Accessed 30 Oct 2021) (2019). – reference: BaiJLeeSRyuSIdentification and in vitro characterization of a novel phage endolysin that targets Gram-negative bacteriaMicroorganisms202084471:CAS:528:DC%2BB3cXhsVWjsLfE714399210.3390/microorganisms8030447 – reference: SödingJBiegertALupasANThe HHpred interactive server for protein homology detection and structure predictionNucleic Acids Res.200533W244W24815980461116016910.1093/nar/gki408 – reference: KimBOPhage-derived antibacterials: Harnessing the simplicity, plasticity, and diversity of phagesViruses2019112681:CAS:528:DC%2BC1MXhslymur3J646613010.3390/v11030268 – reference: MinhBQNguyenMAvon HaeselerAUltrafast approximation for phylogenetic bootstrapMol. Biol. Evol.201330118811951:CAS:528:DC%2BC3sXlvFWgsb0%3D23418397367074110.1093/molbev/mst024 – reference: LipskiAStructural and biochemical characterization of the β-N-acetylglucosaminidase from Thermotoga maritima: Toward rationalization of mechanistic knowledge in the GH73 familyGlycobiology2015253193301:CAS:528:DC%2BC28Xht1Wqu77O2534444510.1093/glycob/cwu113 – reference: VollmerWBlanotDde PedroMAPeptidoglycan structure and architectureFEMS Microbiol. Rev.2008321491671:CAS:528:DC%2BD1cXjt1Git7k%3D1819433610.1111/j.1574-6976.2007.00094.x – reference: Rambaut, A. FigTree v. 1.4.4. http://tree.bio.ed.ac.uk/software/figtree/ (2018). – reference: FokineAMiroshnikovKAShneiderMMMesyanzhinovVVRossmannMGStructure of the bacteriophage phiKZ lytic transglycosylase gp144J. Biol. Chem.2008283724275501:CAS:528:DC%2BD1cXivFyisr8%3D1816039410.1074/jbc.M709398200 – reference: GondilVSHarjaiKChhibberSEndolysins as emerging alternative therapeutic agents to counter drug-resistant infectionsInt. J. Antimicrob. Agents2020551:CAS:528:DC%2BB3cXht1Sit7c%3D3171525710.1016/j.ijantimicag.2019.11.001 – reference: BriersYLavigneRBreaking barriers: Expansion of the use of endolysins as novel antibacterials against Gram-negative bacteriaFuture Microbiol.2015103773901:CAS:528:DC%2BC2MXltlCrsLw%3D2581246110.2217/fmb.15.8 – reference: LaiMJAntibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteriaAppl. Microbiol. Biotechnol.2011905295391:CAS:528:DC%2BC3MXjsFGhs7Y%3D2126446610.1007/s00253-011-3104-y – reference: BriersYPeetersLMVolckaertGLavigneRThe lysis cassette of bacteriophage ϕKMV encodes a signal-arrest-release endolysin and a pinholinBacteriophage20111253021687532310945110.4161/bact.1.1.14868 – reference: GraschopfABläsiUMolecular function of the dual-start motif in the lambda S holinMol. Microbiol.1999335695821:CAS:528:DyaK1MXlslSjur4%3D1041764710.1046/j.1365-2958.1999.01501.x – reference: LiebschnerDMacromolecular structure determination using X-rays, neutrons and electrons: Recent developments in PhenixActa Crystallogr. D Struct. Biol.2019758618771:CAS:528:DC%2BC1MXhvFWkurrO31588918677885210.1107/S2059798319011471 – reference: KongariRPhage spanins: Diversity, topological dynamics and gene convergenceBMC Bioinform.2018193261:CAS:528:DC%2BC1MXht1Sks7%2FO10.1186/s12859-018-2342-8 – reference: KazaksADislersALipowskyGNikolajevaVTarsKComplete genome sequence of the Enterobacter cancerogenus bacteriophage Enc34J. Virol.20128611403114041:CAS:528:DC%2BC38XhsVyqsr3I22997422345718510.1128/JVI.01954-12 – reference: HolmLDALI and the persistence of protein shapeProtein Sci.2020291281401:CAS:528:DC%2BC1MXitFWjsbzO3160689410.1002/pro.3749 – reference: KalyaanamoorthySMinhBQWongTvon HaeselerAJermiinLSModelFinder: Fast model selection for accurate phylogenetic estimatesNat. Methods2017145875891:CAS:528:DC%2BC2sXntFKitbw%3D28481363545324510.1038/nmeth.4285 – reference: Artola-RecolonsCStructure and cell wall cleavage by modular lytic transglycosylase MltC of Escherichia coliACS Chem. Biol.20149205820661:CAS:528:DC%2BC2cXhtVyitLzK24988330416878310.1021/cb500439c – reference: AshkenazyHConSurf 2016: An improved methodology to estimate and visualize evolutionary conservation in macromoleculesNucleic Acids Res.201644W344W3501:CAS:528:DC%2BC2sXhtV2itrrJ27166375498794010.1093/nar/gkw408 – reference: ChertkovOVDual active site in the endolytic transglycosylase gp144 of bacteriophage phiKZActa Nat.2017981871:STN:280:DC%2BC1crjtVKjug%3D%3D10.32607/20758251-2017-9-1-81-87 – reference: GerstmansHCrielBBriersYSynthetic biology of modular endolysinsBiotechnol. Adv.2018366246401:CAS:528:DC%2BC1cXkvFyhtg%3D%3D2924868210.1016/j.biotechadv.2017.12.009 – reference: CernookaERumnieksJKazaksAStructural characterization of a single-stranded DNA-binding protein: A case study of the ORF6 protein from bacteriophage Enc34Methods Mol. Biol.202122813433731:CAS:528:DC%2BB3MXisFals7%2FK3384797110.1007/978-1-0716-1290-3_23 – volume: 44 start-page: W344 year: 2016 ident: 8765_CR26 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkw408 – ident: 8765_CR46 – volume: 66 start-page: 125 year: 2010 ident: 8765_CR49 publication-title: Acta Crystallogr. D Biol. Crystallogr. doi: 10.1107/S0907444909047337 – volume: 6 start-page: 100 year: 2020 ident: 8765_CR8 publication-title: Palgrave Commun. doi: 10.1057/s41599-020-0478-4 – volume: 9 start-page: 1261 year: 2019 ident: 8765_CR32 publication-title: Sci. Rep. doi: 10.1038/s41598-018-37417-6 – volume: 90 start-page: 529 year: 2011 ident: 8765_CR17 publication-title: Appl. Microbiol. Biotechnol. doi: 10.1007/s00253-011-3104-y – volume: 66 start-page: 486 year: 2010 ident: 8765_CR52 publication-title: Acta Crystallogr. D Biol. Crystallogr. doi: 10.1107/S0907444910007493 – volume: 101 start-page: 6415 year: 2004 ident: 8765_CR16 publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0400957101 – volume: 65 start-page: 105 year: 2004 ident: 8765_CR31 publication-title: Appl. Microbiol. Biotechnol. doi: 10.1007/s00253-003-1522-1 – volume: 37 start-page: 1530 year: 2020 ident: 8765_CR43 publication-title: Mol. Biol. Evol. doi: 10.1093/molbev/msaa015 – volume: 9 start-page: 155 year: 2020 ident: 8765_CR6 publication-title: Antibiotics (Basel) doi: 10.3390/antibiotics9040155 – volume: 2281 start-page: 343 year: 2021 ident: 8765_CR47 publication-title: Methods Mol. Biol. doi: 10.1007/978-1-0716-1290-3_23 – volume: 33 start-page: 569 year: 1999 ident: 8765_CR20 publication-title: Mol. Microbiol. doi: 10.1046/j.1365-2958.1999.01501.x – volume: 9 start-page: 1033 year: 2018 ident: 8765_CR18 publication-title: Front. Microbiol. doi: 10.3389/fmicb.2018.01033 – volume: 10 start-page: 377 year: 2015 ident: 8765_CR15 publication-title: Future Microbiol. doi: 10.2217/fmb.15.8 – volume: 1 start-page: 25 year: 2011 ident: 8765_CR34 publication-title: Bacteriophage doi: 10.4161/bact.1.1.14868 – volume: 49 start-page: 1085 year: 2016 ident: 8765_CR50 publication-title: J. Appl. Crystallogr. doi: 10.1107/S1600576716004416 – volume: 27 start-page: 293 year: 2018 ident: 8765_CR55 publication-title: Protein Sci. doi: 10.1002/pro.3330 – volume: 12 year: 2021 ident: 8765_CR11 publication-title: Front. Microbiol. doi: 10.3389/fmicb.2021.748718 – volume: 52 start-page: 243 year: 2014 ident: 8765_CR33 publication-title: J. Microbiol. doi: 10.1007/s12275-014-4087-z – ident: 8765_CR1 – volume: 11 start-page: 268 year: 2019 ident: 8765_CR7 publication-title: Viruses doi: 10.3390/v11030268 – volume: 29 start-page: 128 year: 2020 ident: 8765_CR25 publication-title: Protein Sci. doi: 10.1002/pro.3749 – volume: 25 start-page: 319 year: 2015 ident: 8765_CR27 publication-title: Glycobiology doi: 10.1093/glycob/cwu113 – volume: 36 start-page: 624 year: 2018 ident: 8765_CR13 publication-title: Biotechnol. Adv. doi: 10.1016/j.biotechadv.2017.12.009 – volume: 110 start-page: 879 year: 2018 ident: 8765_CR14 publication-title: Mol. Microbiol. doi: 10.1111/mmi.14134 – volume: 30 start-page: 1188 year: 2013 ident: 8765_CR45 publication-title: Mol. Biol. Evol. doi: 10.1093/molbev/mst024 – volume: 19 start-page: 326 year: 2018 ident: 8765_CR21 publication-title: BMC Bioinform. doi: 10.1186/s12859-018-2342-8 – volume: 8 start-page: e00188 year: 2019 ident: 8765_CR29 publication-title: Microbiol. Resour. Announc. doi: 10.1128/MRA.00188-19 – volume: 55 year: 2020 ident: 8765_CR12 publication-title: Int. J. Antimicrob. Agents doi: 10.1016/j.ijantimicag.2019.11.001 – volume: 37 start-page: 420 year: 2019 ident: 8765_CR41 publication-title: Nat. Biotechnol. doi: 10.1038/s41587-019-0036-z – volume: 14 start-page: 587 year: 2017 ident: 8765_CR44 publication-title: Nat. Methods doi: 10.1038/nmeth.4285 – volume: 70 start-page: 531 year: 2007 ident: 8765_CR22 publication-title: J. Biochem. Biophys. Methods doi: 10.1016/j.jbbm.2006.10.009 – volume: 20 start-page: e216 year: 2020 ident: 8765_CR5 publication-title: Lancet Infect. Dis. doi: 10.1016/S1473-3099(20)30327-3 – volume: 40 start-page: 658 year: 2007 ident: 8765_CR54 publication-title: J. Appl. Crystallogr. doi: 10.1107/S0021889807021206 – volume: 283 start-page: 7242 year: 2008 ident: 8765_CR35 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M709398200 – volume: 67 start-page: 355 year: 2011 ident: 8765_CR53 publication-title: Acta Crystallogr. D Biol. Crystallogr. doi: 10.1107/S0907444911001314 – volume: 86 start-page: 11403 year: 2012 ident: 8765_CR19 publication-title: J. Virol. doi: 10.1128/JVI.01954-12 – volume: 4 start-page: 1862 year: 2019 ident: 8765_CR2 publication-title: Nat. Microbiol. doi: 10.1038/s41564-019-0531-5 – volume: 22 start-page: 1038 year: 2017 ident: 8765_CR37 publication-title: Molecules doi: 10.3390/molecules22071038 – ident: 8765_CR24 – volume: 305 start-page: 567 year: 2001 ident: 8765_CR40 publication-title: J. Mol. Biol. doi: 10.1006/jmbi.2000.4315 – volume: 61 start-page: 2753 year: 2004 ident: 8765_CR48 publication-title: Cell. Mol. Life Sci. doi: 10.1007/s00018-004-4301-y – volume: 477 start-page: 457 year: 2011 ident: 8765_CR3 publication-title: Nature doi: 10.1038/nature10388 – volume: 9 start-page: 81 year: 2017 ident: 8765_CR28 publication-title: Acta Nat. doi: 10.32607/20758251-2017-9-1-81-87 – volume: 33 start-page: W244 year: 2005 ident: 8765_CR39 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gki408 – volume: 75 start-page: 861 year: 2019 ident: 8765_CR51 publication-title: Acta Crystallogr. D Struct. Biol. doi: 10.1107/S2059798319011471 – volume: 8 start-page: 447 year: 2020 ident: 8765_CR30 publication-title: Microorganisms doi: 10.3390/microorganisms8030447 – volume: 40 start-page: 344 year: 2015 ident: 8765_CR4 publication-title: P T – volume: 9 start-page: 2058 year: 2014 ident: 8765_CR36 publication-title: ACS Chem. Biol. doi: 10.1021/cb500439c – volume: 36 start-page: W5 year: 2008 ident: 8765_CR38 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkn201 – volume: 32 start-page: 149 year: 2008 ident: 8765_CR23 publication-title: FEMS Microbiol. Rev. doi: 10.1111/j.1574-6976.2007.00094.x – volume: 7 start-page: 539 year: 2011 ident: 8765_CR42 publication-title: Mol. Syst. Biol. doi: 10.1038/msb.2011.75 – volume: 7 start-page: 1147 year: 2012 ident: 8765_CR10 publication-title: Future Microbiol. doi: 10.2217/fmb.12.97 – volume: 13 start-page: 680 year: 2021 ident: 8765_CR9 publication-title: Viruses doi: 10.3390/v13040680 |
| SSID | ssj0000529419 |
| Score | 2.4149413 |
| Snippet | Endolysins are bacteriophage-encoded peptidoglycan-degrading enzymes with potential applications for treatment of multidrug-resistant bacterial infections.... Abstract Endolysins are bacteriophage-encoded peptidoglycan-degrading enzymes with potential applications for treatment of multidrug-resistant bacterial... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 5005 |
| SubjectTerms | 631/337 631/535 Bacteria Bacterial diseases Bacteriophages - metabolism Catalytic Domain Conserved sequence Crystal structure Endopeptidases - metabolism Enzymes Glycoside hydrolase Gram-negative bacteria Humanities and Social Sciences Lysozyme multidisciplinary Multidrug resistance Muramidase - metabolism Opportunist infection Peptidoglycan - metabolism Peptidoglycans Phages Science Science (multidisciplinary) Turbidity |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9UwELZQBRIXxE5oQUbiBlGdOIvdG0srThUHkHqLvIzVJ7061UtTKfx6xnby6GO9cI2deDSL_Tkef0PIa9DWSWbbvK0alleaF7mCkPbHKqed5bWei020p6fi7Ex-vlHqK-SEJXrgpLjDRtraFQK0wq0MQKlYY5kpS6MsjiFNmH0R9dzYTCVW71JWhZxvyTAuDgdcqcJtMtx7BRa2Oi92VqJI2P87lPlrsuRPJ6ZxITq5T-7NCJK-S5I_ILfAPyR3Uk3J6RHZfFwyLWjvKMI7up6G_tt0AdT1a3tEE2PsuIGlPf7BmfBr1PYXauVpuHJClaejH4cRhwJv-8Bc4mlgvbRgqZ7o5TnORPTYG149Jl9Pjr98-JTPhRVyU7XsKpesdtAIhE7QAlNSMVSnKoEzJ1vUkK6EbbUqOIINLUEpbSXCKqsN4hXNgD8he7738IxQbhsn65KZtlSVAKel5fg9aArFG8VNRopFyZ2ZWcdD8Yt1F0-_ueiSYToctouG6YqMvNm-c5k4N_7a-32w3bZn4MuOD9CLutmLun95UUYOFst3cxAPXRkuAYuGNzwjr7bNGH7hTEV56MfURwhEcSIjT5OjbCXhNc6WiAYy0u640I6ouy1-dR4pviMrfl1n5O3ibD_E-rMqnv8PVeyTu2WMEp6X_IDsoVPCC3LbXF-ths3LGGbfAZEvLKE priority: 102 providerName: Directory of Open Access Journals |
| Title | Diversity of the lysozyme fold: structure of the catalytic domain from an unusual endolysin encoded by phage Enc34 |
| URI | https://link.springer.com/article/10.1038/s41598-022-08765-1 https://www.ncbi.nlm.nih.gov/pubmed/35322067 https://www.proquest.com/docview/2642186363 https://www.proquest.com/docview/2642885848 https://pubmed.ncbi.nlm.nih.gov/PMC8943055 https://doaj.org/article/69d5f18eba254ee2a06d0c22cad90d9c |
| Volume | 12 |
| WOSCitedRecordID | wos000772605500123&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M7P dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: 7X7 dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: BENPR dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: PIMPY dateStart: 20110101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVPQU databaseName: Science Database customDbUrl: eissn: 2045-2322 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000529419 issn: 2045-2322 databaseCode: M2P dateStart: 20110101 isFulltext: true titleUrlDefault: https://search.proquest.com/sciencejournals providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELbYFiQuvB-BpTISN4jWiZPY5oJY6AoOW1UIpHKK7NhhK3Wd0myRwq9n7DhdlcdeuPgQO4mdGY-_zNjfIPTCKF0LolnMsoLEmaJJLI3b9keyWtWa5iokm2CzGV8sxDw43NqwrXKwid5Q66ZyPvKj1J3I5AUt6Jv199hljXLR1ZBC4wCNHVNZNkLj4-ls_mnnZXFxrCwR4bQMofyohRXLnSqDfzDHxpbHyd6K5In7_4Y2_9w0-Vvk1C9IJ7f_dyh30K0ARfHbXnfuomvG3kM3-uSU3X20eT9s2cBNjQEn4lXXNj-7c4PrZqVf4556drsxQ713BXXwNKybc7m02J1dwdLird22W3iVsbpxFCgWO_pMbTRWHV6fgUnDU1vR7AH6cjL9_O5DHDI0xFXGyEUsSF6bggMGM8wQKSRJKylTQ0ktGHxilXHNlEwooBYljJRKC8BnWlUAfBQx9CEa2caaxwhTXdQiT0nFUplxUyuhKTzPFImkhaRVhJJBSmUV6MtdFo1V6cPolJe9ZEt4beklWyYRerm7Z92Td1zZ-tgJf9fSEW_7C83mWxnmcVkIndcJN0rCn7UxqSSFJlUKw9ag8gK6eTjIvAzWoC0vBR6h57tqmMcuOCOtabZ9G84BDvIIPeo1bdcTmoPZBVgRIbang3td3a-xyzPPFe7p9fM8Qq8Gbb3s1r8_xZOrR_EU3Uz9BKJxSg_RCNTNPEPXqx8Xy3YzQQdswXzJJ2E-TryrA8rTdO5KBuV4_vF0_vUX0DBBOw |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKAcGFfQkUMBKcIKpjJ3GMhBDQVq1aRhyKNDdjxw4daeoMkw4o_Ch-I89OMtWw9NYD19hxbOd7i_02hJ5ZbSpBDI95mpM41SyJlfVufyStdGVYpvtiE3w0KsZj8XEN_RxiYbxb5cATA6M2denvyDepj8gscpazN7Ovsa8a5a2rQwmNDhb7tv0OR7bm9d4W_N_nlO5sH77fjfuqAnGZcnISC5JVNi9Ab7DcEiUUoaVS1DJSCQ4STaeF4VolDCStFlYpbQToFEaXIKw1sQzGvYAuAh_n3oWMj_nyTsdbzdJE9LE5hBWbDchHH8MGJz6f-y2LkxX5F8oE_E23_dNF8zc7bRB_O9f_t427ga71ijZ-21HGTbRm3S10uSu92d5G863BIQXXFQYtGE_bpv7RHltc1VPzCneJdRdzO7SHi64WRsOmPlYTh31kDlYOL9yiWcCnrDO1T_DisE8OaqzBusWzI2DYeNuVLL2DPp3Lgu-idVc7ex9hZvJKZJSUnKq0sJUWhsF4Nk8UyxUrI5QMqJBln5zd1wiZyuAkwArZIUnCZ2VAkkwi9GL5zqxLTXJm73cebMuePq14eFDPv8ieS8lcmKxKCqsVzVJrqSK5ISWFZRsgaAHT3BgwJnte18hTgEXo6bIZuJQ3PSln60XXpyhA2S0idK9D9nImLAOhAkpThPgK5lemutriJkchE3ooHpBlEXo5UMfptP69FQ_OXsUTdGX38MOBPNgb7T9EV2kgXhZTtoHWAXr2EbpUfjuZNPPHgfox-nzeVPMLEZ-XDQ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKWcSFfQkUMBKcIBrHzmYkhIDpiKowmgNIvRk7duhIU2eYNKDw0_h1PDvJVMPSWw9cY8exne8t9tsQemKULjnRWZjFKQljxaJQGuf2R-JSlZolqi82kU2n-cEBn22hn0MsjHOrHHiiZ9S6Ktwd-Yi6iMw8ZSkblb1bxGw8ebX8GroKUs7SOpTT6CCyb9rvcHyrX-6N4V8_pXSy-_Htu7CvMBAWcUaOQ06S0qQ56BAmM0RySWghJTWMlDwD6abiXGdKRgykruJGSqU56BdaFSC4FTEMxj2Hzmdxkjjq-kBn6_sdZ0GLI97H6RCWj2qQlS6eDU5_Lg9cEkYbstCXDPibnvunu-ZvNlsvCidX_-dNvIau9Ao4ft1RzHW0ZewNdLErydneRKvx4KiCqxKDdowXbV39aI8MLquFfoG7hLvNygzt_gKshdGwro7k3GIXsYOlxY1t6gY-ZayuXOIXi13SUG00Vi1eHgIjx7u2YPEt9OlMFnwbbdvKmrsIM52WPKGkyKiMc1MqrhmMZ9JIslSyIkDRgBBR9EnbXe2QhfDOAywXHaoEfFZ4VIkoQM_W7yy7lCWn9n7jgLfu6dKN-wfV6ovouZdIuU7KKDdK0iQ2hkqSalJQWLYGQucwzZ0Bb6LngbU4AVuAHq-bgXs5k5S0pmq6PnkOSnAeoDsdytczYQkIG1CmApRt4H9jqpstdn7oM6T7ogJJEqDnA6WcTOvfW3Hv9FU8QpeAWMT7ven-fXSZejpmIWU7aBuQZx6gC8W343m9eugZAUafz5pofgEdX5_a |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diversity+of+the+lysozyme+fold%3A+structure+of+the+catalytic+domain+from+an+unusual+endolysin+encoded+by+phage+Enc34&rft.jtitle=Scientific+reports&rft.au=Cernooka+Elina&rft.au=Rumnieks+Janis&rft.au=Zrelovs+Nikita&rft.au=Tars+Kaspars&rft.date=2022-03-23&rft.pub=Nature+Publishing+Group&rft.eissn=2045-2322&rft.volume=12&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-022-08765-1&rft.externalDBID=HAS_PDF_LINK |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |